Spinogenix
Clinical trials sponsored by Spinogenix, explained in plain language.
-
New ALS drug trial aims to slow disease progression
Disease control Not yet recruitingThis study tests whether the experimental drug tazbentetol can slow the decline in physical function for people with ALS. About 430 adults aged 18-80 with ALS will receive either the drug or a placebo. The main goal is to see if tazbentetol helps maintain daily living abilities o…
Phase: PHASE2, PHASE3 • Sponsor: Spinogenix • Aim: Disease control
Last updated May 26, 2026 11:35 UTC
-
New drug trial aims to boost brain function in fragile x
Symptom relief Not yet recruitingThis study tests an experimental drug called SPG601 in 248 adult men with Fragile X syndrome. The goal is to see if it can improve thinking, learning, and brain activity. Participants will be randomly assigned to receive either the drug or a placebo, and neither they nor the rese…
Phase: PHASE2, PHASE3 • Sponsor: Spinogenix • Aim: Symptom relief
Last updated May 26, 2026 11:30 UTC